Nemocnica S Poliklinikou Trebisov a.s. — Clinical Trial Site

9 Registered trials

4 Currently recruiting

Organisation

Nemocnica S Poliklinikou Trebisov a.s.

Location

Trebisov, Slovakia

Identifier

ORG-100041784

Address

Slov. Nar. Povstania 76, 075 01, Slovakia

Departments

Oftalmologicka ambulancia
Oftalmologicka ambulancia III.
Oftalmologicka ambulancia III.-kataraktova a refrakcna chirurgia
Ophtalmology
Ophthalmic one-day health care
Ophthalmology

Clinical trials at this site (9)

Search interface

A clinical trial of EYE201/MK-8748 in people with macular degeneration (MK-8748-003) Recruiting

2025-524894-17-00 Neovascular age-related macular degeneration (NVAMD) 10 2026-06-22
COMO: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME Recruiting

2025-523937-25-00 Diabetic Macular Edema (DME) 5 2026-05-06
Clinical Study to Compare Efficacy and Safety of AVT29 and Eylea HD in Participants with Diabetic Macular Edema Recruiting

2025-522231-34-00 Diabetic Macular Edema 5 2026-03-31
A study to test whether BI 1815368 helps people with an eye condition called diabetic macular edema Recruiting

2024-520384-14-00 Centre-involved diabetic macular edema 4 2025-11-20
A randomized study to evaluate the Efficacy and Safety of Intravitreal EYE103 Compared to Anti-VEGF Ended

2025-520809-12-00 Diabetic Macular Edema 10 2025-10-16
LUCIA: A Phase 3 randomized, double-masked study comparing the efficacy of EYP-1901 against aflibercept Ended

2024-518030-83-00 Wet age-related macular degeneration (wAMD) 5 2025-06-05
A randomized study to evaluate the Efficacy and Safety of Intravitreal EYE103 Compared to Anti-VEGF (in patients with Diabetic Macular Edema… Ended

2024-510944-30-00 Diabetic Macular Edema 10 2024-11-22
A clinical study of OPT-302 with aflibercept compared to aflibercept alone in patients with neovascular age-related macular degeneration Ended

2024-512880-30-00 Neovascular Age-related Macular Degeneration (wet AMD) 5 2021-08-27
A Multicenter, Randomized, Double-Masked, Vehicle-Controlled Study to Assess the Safety and Efficacy of SYD-101 Ophthalmic Solution for the … Ended

2023-509134-19-00 Myopia 5 2019-10-23